SIK1 and type 2 diabetes mellitus: In the present study, the administration of Ad-SIK1 resulted in amelioration of hyperglycaemia in HFD/STZ-induced diabetic rats, suggesting that exogenous SIK1 might have a protective effect on T2DM.